Loading organizations...
Loading organizations...
Biotechnology company advancing genome engineering with ForgeCraft platform
Muse Bio has raised $23.0M across 1 funding round.
Muse Bio has raised $23.0M in total across 1 funding round.
Muse Bio has raised $23.0M in total across 1 funding round.
Muse Bio's investors include Bryan Roberts, Foresite Capital, NanoDimension, Paladin Capital Group, Spruce Capital Partners.
Muse Bio has raised $23.0M across 1 funding round. Most recently, it raised $23.0M Series B in February 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 28, 2017 | $23.0M Series B | Bryan Roberts | Foresite Capital, NanoDimension, Paladin Capital Group, Spruce Capital Partners |